HLS Therapeutics Inc T.HLS

Alternate Symbol(s): HLTRF

HLS Therapeutics Inc. is a pharmaceutical company. It is focused on the acquisition and commercialization of late-stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. It is engaged in addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease. It is also focused on products targeting the central nervous system and cardiovascular therapeutic areas. Its products include Clozaril, CSAN Pronto, MyCare Insite, MyCare Psychiatry, PERSERIS, Trinomia and Vascepa. Its lead product is Clozaril, which is an atypical antipsychotic indicated for the management of symptoms of treatment-resistant schizophrenia for the Canadian and United States markets. CSAN Pronto is a capillary point-of-care medical device designed to enhance and simplify the mandatory safety blood monitoring process for patients that are prescribed Clozaril. Trinomia product related to the treatment of cardiovascular disease.

TSX:HLS - Post by User

HLS Therapeutics Inc

Bullboard Posts

Post by pagoda3xon Jan 03, 2018 8:46pm

167 Views

Post# 27276147

Move your shares into your RRSP

Considering the tax implications, I would strongly recommend that you move your shares into your RRSP or TFSA.

As for the merger, I have total confidence in the management of AM.
Over the years they have proved themselves to be shareholders friendly.
They were generous with dividends and they did NOT award themselves a generous option plan.

Bullboard Posts

Xplore Resources to expand position near Surge Lithium Project